The Effect of Dignity Therapy Applied to Cancer Patients

NCT06105359 | Completed

• 1 other identifier: Necmettin Erbakan University1
• Study Type: interventional
• Target: 48
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study is to determine the effect of dignity therapy on the quality of life and depression levels of cancer patients. Methods: The research was planned as a randomized controlled experimental study. Type of Research: Research, experimental, control group and pretest-posttest study will be carried out. Population of the Study: The population of the study was sent to Meram Medical Faculty Hospital Oncology Clinic consists of male and female inpatients. Sample of the Research: Those who agreed to participate in the research and met the inclusion criteria. Patients who meet will be included in the study. It was 48. It was planned to be. Randomization: In this study, parallel group block randomization method was applied to the intervention and control groups. will be allocated randomly. Block randomization was used because the sample size was small. Patients will be selected equally using permutation method, and randomization will be selected using blocking technique. will be done. During randomization, CONSORT 2017 will be used. For randomization; To control for performance bias, patients will be blinded to the study hypothesis and will not be informed which group they are in. There will be no blinding for the researcher. However, blind technique will be used in the research. This blind technique will be applied by the researcher with the patients blinded until the application begins.. Data Collection Techniques and Tools: "Personal Information Form", "Patient Dignity Inventory" and "Rosenberg Self-Esteem Scale" were used in data collection (RSES)" will be used.

Conditions

Cancer; Dignity

Keywords

Dignity therapy; cancer patient; depression

Outcome Measures

Primary Outcomes (1)

• Patient Dignity Inventory

  The scale, consisting of a total of 25 items, was developed by Chochinov et al. (2008) and translated into Turkish by Eskigülek and Kav (2022) adapted. The minimum and maximum total score of the inventory is 25 and 125 points respectively. There are no reverse scored items in the inventory. A higher total score means that the individual's perceived reputation is complex. Items scoring three or more are clinically significant. As a result of factor analysis, a five-factor structure was obtained; The factors are reported as "symptom distress", "existential distress", "addiction", "peace of mind" and "social support"

  Baseline (Day 0) and Day 10

Secondary Outcomes (2)

• Personal Information Form

  Baseline (Day 0) and Day 10

• Rosenberg Self-Esteem Scale

  Baseline (Day 0) and Day 10

Study Arms (2)

experimental group

EXPERIMENTAL

Patients in this group will be treated with dignity therapy by the researcher.

Behavioral: Dignity therapy

control group

ACTIVE COMPARATOR

Patients in this group will receive standard care and no treatment will be performed by the researcher.

Other: Routine Care

Interventions

Routine Care OTHER

The control group will receive routine clinical care as provided by the oncology clinic. No additional psychological or supportive intervention will be administered by the researchers to this group during the study period.

control group

Dignity therapy BEHAVIORAL

Dignity therapy will be applied in the interview room that will be requested in the oncology clinic to protect the confidentiality of information. The application is planned as five sessions and the sessions will last approximately 40 minutes. Two questions in the dignity therapy protocol will be discussed in each session.

experimental group

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Able to speak and understand Turkish,
• Those over 18 years of age
• No communication barriers
• Cancer diagnosis is in the 4th stage and in the last stage
• Patients with a predicted survival time of less than 6 months (physician opinion) will be included

You may not qualify if:

• Those diagnosed with dementia, delirium or other organic brain disorders;
• Those with impaired consciousness;
• Patients with mental problems that prevent them from receiving esteem therapy will be excluded

Sponsors & Collaborators

• Necmettin Erbakan University: lead

Study Sites (1)

Necmettin Erbakan Üniversitesi

Konya, 42080, Turkey (Türkiye)

Location

Related Publications (1)

• Chochinov HM. Dignity-conserving care--a new model for palliative care: helping the patient feel valued. JAMA. 2002 May 1;287(17):2253-60. doi: 10.1001/jama.287.17.2253.

  PMID: 11980525 RESULT

MeSH Terms

Conditions

Neoplasms; Depression

Interventions

Dignity Therapy

Condition Hierarchy (Ancestors)

Behavioral Symptoms; Behavior

Intervention Hierarchy (Ancestors)

Psychotherapy; Behavioral Disciplines and Activities

Study Officials

• NESIBE GÜNAY MOLU

  Necmettin Erbakan University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Masking Details: To control for performance bias, patients will be blinded to the study hypothesis and will not be informed which group they are in. There will be no blinding for the researcher. However, blind technique will be used in the research. This blind technique will be applied by the researcher with the patients blinded until the application begins. In the research, in order to meet the blind technical conditions, the process steps were carried out by an independent statistician from the first stage. The sample will be sorted by a combination order and number. In this way selection bias will be controlled. The study will also be controlled for attrition bias and Statistics and reporting bias.
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assoc. Prof.

Model Details: Research, experimental control group and pretest-posttest study will be carried out.

Study Record Dates

• First Submitted: October 18, 2023
• First Posted: October 27, 2023
• Study Start: January 12, 2023
• Primary Completion: September 15, 2025
• Study Completion: September 15, 2025
• Last Updated: April 9, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)